Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931059 · ClinicalTrials.gov registry record · NA
Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01931059 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 11 participants.
The verdict
NCT01931059, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To detect the effect of second-generation antipsychotic drug on the neural activity.
Interventions
- OTHER Placebo
- DRUG Risperidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01931059
The ClinicalTrials.gov registry entry for NCT01931059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01931059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01931059 about?
NCT01931059 is a clinical study titled "Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers". To detect the effect of second-generation antipsychotic drug on the neural activity.
What is the current status of trial NCT01931059?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01931059?
The interventions under investigation include: Placebo (OTHER), Risperidone (DRUG).
Who is sponsoring clinical trial NCT01931059?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.